Conversion from enzyme-inducing antiepileptic drugs to topiramate: Effects on lipids and c-reactive protein

Epilepsy Research

Volumn 98, Issue 1, 2012, Pages 88-93

  Mintzer, Scott ^a   Skidmore, Christopher T ^a   Rankin, Sara J ^a   Chervoneva, Inna ^b   Pequinot, Edward ^b   Capuzzi, David M ^c   Sperling, Michael R ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antiepileptic drugs; Cholesterol; Cytochrome P450; Enzyme induction

Indexed keywords

C REACTIVE PROTEIN; CARBAMAZEPINE; CHOLESTEROL; CYTOCHROME P450; LIPID; LOW DENSITY LIPOPROTEIN; PHENYTOIN; TOPIRAMATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFECT; DRUG SUBSTITUTION; ENZYME INDUCTION; EPILEPSY; FEMALE; HUMAN; LIPID BLOOD LEVEL; LOW DRUG DOSE; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; C-REACTIVE PROTEIN; CARBAMAZEPINE; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; LIPIDS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PHENYTOIN;

EID: 83555178400     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.10.001     Document Type: Article

References (17)

1. Bramswig S., Sudhop T., Luers C., von Bergmann K., Berthold H.K. Lipoprotein(a) concentration increases during treatment with carbamazepine. Epilepsia 2003, 44:457-460.
2. Cromwell W.C., Otvos J.D. Low-density lipoprotein particle number and risk for cardiovascular disease. Curr. Atheroscler. Rep. 2004, 6:381-387.
3. Doose D.R., Wang S.S., Padmanabhan M., Schwabe S., Jacobs D., Bialer M. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Epilepsia 2003, 44:540-549.
4. El Harchaoui K., van der Steeg W.A., Stroes E.S., Kuivenhoven J.A., Otvos J.D., Wareham N.J., Hutten B.A., Kastelein J.J., Khaw K.T., Boekholdt S.M. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J. Am. Coll. Cardiol. 2007, 49:547-553.
5. Franzoni E., Verrotti A., Sarajlija J., Garone C., Matricardi S., Salerno G.G., Monti M., Chiarelli F. Topiramate: effects on serum lipids and lipoproteins levels in children. Eur. J. Neurol. 2007, 14:1334-1337.
6. Genc B.O., Dogan E.A., Dogan U., Genc E. Anthropometric indexes, insulin resistance, and serum leptin and lipid levels in women with cryptogenic epilepsy receiving topiramate treatment. J. Clin. Neurosci. 2010, 17:1256-1259.
7. Gibbons G.F. The role of cytochrome P450 in the regulation of cholesterol biosynthesis. Lipids 2002, 37:1163-1170.
8. Isojarvi J.I., Pakarinen A.J., Rautio A., Pelkonen O., Myllyla V.V. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Epilepsia 1994, 35:1217-1220.
9. Kocer A., Dikici S., Atakay S., Okuyucu S. Serum uric acid and lipid levels while taking topiramate for migraine. Headache 2008, 48:1056-1060.
10. Mintzer S., Skidmore C.T., Abidin C.J., Morales M.C., Chervoneva I., Capuzzi D.M., Sperling M.R. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann. Neurol. 2009, 65:448-456.
11. Mintzer S., Boppana P., Toguri J., DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006, 47:510-515.
12. Nikolaos T., Stylianos G., Chryssoula N., Irini P., Christos M., Dimitrios T., Konstantinos P., Antonis T The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med. Sci. Monit. 2004, 10(MT50-2).
13. Rosenfeld W.E., Doose D.R., Walker S.A., Nayak R.K. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia 1997, 38:317-323.
14. Rosenson R.S., Otvos J.D., Freedman D.S. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am. J. Cardiol. 2002, 90:89-94.
15. Tan T.Y., Lu C.H., Chuang H.Y., Lin T.K., Liou C.W., Chang W.N., Chuang Y.C. Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia 2009, 50:1579-1586.
16. Verrotti A., Scaparrotta A., Agostinelli S., Di Pillo S., Chiarelli F., Grosso S. Topiramate-induced weight loss: a review. Epilepsy Res. 2011, 95:189-199.
17. Yohai V.J. High breakdown point and high efficiency robust estimates for regression. Ann. Stat. 1987, 15:642-656.